Literature DB >> 12242174

Accumulation of prion protein in tonsil and appendix: review of tissue samples.

David A Hilton1, Azra C Ghani, Lisa Conyers, Philip Edwards, Linda McCardle, Mark Penney, Diane Ritchie, James W Ironside.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12242174      PMCID： PMC126304          DOI： 10.1136/bmj.325.7365.633

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Preclinical test for prion diseases.

Authors:  B E Schreuder; L J van Keulen; M E Vromans; J P Langeveld; M A Smits
Journal:  Nature       Date:  1996-06-13       Impact factor: 49.962

2.  Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease.

Authors:  D A Hilton; E Fathers; P Edwards; J W Ironside; J Zajicek
Journal:  Lancet       Date:  1998-08-29       Impact factor: 79.321

Review 3.  Variant Creutzfeldt-Jakob disease.

Authors:  J Collinge
Journal:  Lancet       Date:  1999-07-24       Impact factor: 79.321

4.  Preclinical diagnosis of scrapie by immunohistochemistry of third eyelid lymphoid tissue.

Authors:  K I O'Rourke; T V Baszler; T E Besser; J M Miller; R C Cutlip; G A Wells; S J Ryder; S M Parish; A N Hamir; N E Cockett; A Jenny; D P Knowles
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

5.  Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples.

Authors:  A F Hill; R J Butterworth; S Joiner; G Jackson; M N Rossor; D J Thomas; A Frosh; N Tolley; J E Bell; M Spencer; A King; S Al-Sarraj; J W Ironside; P L Lantos; J Collinge
Journal:  Lancet       Date:  1999-01-16       Impact factor: 79.321
  5 in total
  20 in total

1.  Recipients of blood or blood products "at vCJD risk".

Authors:  Sheila M Bird
Journal:  BMJ       Date:  2004-01-17

Review 2.  American fresh frozen plasma for neonates and children.

Authors:  D R Norfolk; A Glaser; S Kinsey
Journal:  Arch Dis Child       Date:  2005-01       Impact factor: 3.791

3.  Projections of the future course of the primary vCJD epidemic in the UK: inclusion of subclinical infection and the possibility of wider genetic susceptibility.

Authors:  Paul Clarke; Azra C Ghani
Journal:  J R Soc Interface       Date:  2005-03-22       Impact factor: 4.118

4.  Clearance and prevention of prion infection in cell culture by anti-PrP antibodies.

Authors:  Joanna Pankiewicz; Frances Prelli; Man-Sun Sy; Richard J Kascsak; Regina B Kascsak; Daryl S Spinner; Richard I Carp; Harry C Meeker; Marcin Sadowski; Thomas Wisniewski
Journal:  Eur J Neurosci       Date:  2006-05       Impact factor: 3.386

Review 5.  Variant Creutzfeldt-Jakob disease: a cause for concern. Review of the evidence for risk of transmission through abdominal lymphoreticular tissue surgery.

Authors:  S B Olsen; A Sheikh; D Peck; A Darzi
Journal:  Surg Endosc       Date:  2005-05-04       Impact factor: 4.584

Review 6.  Prion diseases.

Authors:  Edward McKintosh; Sarah J Tabrizi; John Collinge
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

7.  Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study.

Authors:  James W Ironside; Matthew T Bishop; Kelly Connolly; Doha Hegazy; Suzanne Lowrie; Margaret Le Grice; Diane L Ritchie; Linda M McCardle; David A Hilton
Journal:  BMJ       Date:  2006-04-10

8.  Factors determining the pattern of the variant Creutzfeldt-Jakob disease (vCJD) epidemic in the UK.

Authors:  Azra C Ghani; Neil M Ferguson; Christl A Donnelly; Roy M Anderson
Journal:  Proc Biol Sci       Date:  2003-04-07       Impact factor: 5.349

9.  Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease.

Authors:  D A Hilton; J Sutak; M E F Smith; M Penney; L Conyers; P Edwards; L McCardle; D Ritchie; M W Head; C A Wiley; J W Ironside
Journal:  J Clin Pathol       Date:  2004-03       Impact factor: 3.411

10.  Follicular dendritic cell dedifferentiation by treatment with an inhibitor of the lymphotoxin pathway dramatically reduces scrapie susceptibility.

Authors:  Neil A Mabbott; Janice Young; Irene McConnell; Moira E Bruce
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.